Asterias Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AST and buy or sell other stocks, ETFs, and their options commission-free!About AST
Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer.
CEOBrian M. Culley, MBA
CEOBrian M. Culley, MBA
Employees—
Employees—
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2012
Founded2012
Employees—
Employees—
AST Key Statistics
Market cap92.97M
Market cap92.97M
Price-Earnings ratio-3.54
Price-Earnings ratio-3.54
Dividend yield—
Dividend yield—
Average volume81.23K
Average volume81.23K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.75
52 Week high$3.75
52 Week low$1.20
52 Week low$1.20
Stock Snapshot
With a market cap of 92.97M, Asterias Biotherapeutics(AST) trades at $0.95. The stock has a price-to-earnings ratio of -3.54.
Asterias Biotherapeutics(AST) stock opened on 2025-12-18 at —. The price climbed to — and dipped to —.
Asterias Biotherapeutics(AST) shares are trading with a volume of 0, against a daily average of 81.23K.
During the past year, Asterias Biotherapeutics(AST) stock moved between $1.20 at its lowest and $3.75 at its peak.
During the past year, Asterias Biotherapeutics(AST) stock moved between $1.20 at its lowest and $3.75 at its peak.